SWTX - SpringWorks Therapeutics, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
Stamford,
United States
Type: Equity
SWTX price evolution
SWTX
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $176.67 | $99.5 | $115.61 | $103.01 |
| Short term investments | $303.15 | $323.52 | $361.71 | $425.74 |
| Net receivables | $5.93 | |||
| Inventory | $3.1 | |||
| Total current assets | $500.91 | $432.38 | $483.9 | $537.66 |
| Long term investments | $185.34 | $3.79 | $4.81 | $5.71 |
| Property, plant & equipment | $24.09 | $27.39 | $25 | $22.33 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $224.88 | $35.27 | $33.43 | $31.54 |
| Total investments | $488.49 | $327.31 | $366.52 | $431.45 |
| Total assets | $725.79 | $467.65 | $517.33 | $569.2 |
| Current liabilities | ||||
| Accounts payable | $7.4 | $5.55 | $3.45 | $6.99 |
| Deferred revenue | $19.55 | $19.55 | $19.55 | $19.55 |
| Short long term debt | $1.06 | $1.16 | $0.81 | $0.39 |
| Total current liabilities | $78.17 | $50.28 | $41.91 | $37.75 |
| Long term debt | $6 | $6.17 | $6.8 | $6.66 |
| Total noncurrent liabilities | $21.4 | $22.47 | $23.98 | $24.52 |
| Total debt | $7.06 | $7.33 | $7.61 | $7.05 |
| Total liabilities | $99.57 | $72.75 | $65.89 | $62.27 |
| Shareholders' equity | ||||
| Retained earnings | -$895.03 | -$800.71 | -$721.27 | -$643.35 |
| Other shareholder equity | $1.19 | -$0.31 | -$0.35 | -$0.16 |
| Total shareholder equity | $626.22 | $394.9 | $451.44 | $506.92 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $176.67 | $68.07 | $104.53 | $147.65 |
| Short term investments | $303.15 | $524.72 | $269.54 | $361.39 |
| Net receivables | $5.93 | |||
| Inventory | $3.1 | |||
| Total current assets | $500.91 | $599.76 | $382.91 | $513.4 |
| Long term investments | $185.34 | $8.99 | $62.11 | $57.21 |
| Property, plant & equipment | $24.09 | $18.27 | $4.2 | $3 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $224.88 | $30.48 | $69.58 | $62.79 |
| Total investments | $488.49 | $533.71 | $331.65 | $418.6 |
| Total assets | $725.79 | $630.24 | $452.49 | $576.2 |
| Current liabilities | ||||
| Accounts payable | $7.4 | $8.01 | $3.43 | $1.4 |
| Deferred revenue | $19.55 | $19.55 | ||
| Short long term debt | $1.06 | $0.48 | $1.16 | $1.38 |
| Total current liabilities | $78.17 | $51.05 | $29.97 | $17.6 |
| Long term debt | $6 | $4.77 | $0.13 | $1.4 |
| Total noncurrent liabilities | $21.4 | $21 | $0.13 | $1.52 |
| Total debt | $7.06 | $5.25 | $1.29 | $2.73 |
| Total liabilities | $99.57 | $72.05 | $30.1 | $19.1 |
| Shareholders' equity | ||||
| Retained earnings | -$895.03 | -$569.93 | -$292.51 | -$118.6 |
| Other shareholder equity | $1.19 | -$0.77 | -$0.31 | $0.04 |
| Total shareholder equity | $626.22 | $558.19 | $422.4 | $557.06 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $5.45 | |||
| Cost of revenue | $0.42 | |||
| Gross Profit | $5.03 | |||
| Operating activities | ||||
| Research & development | $43.65 | $37.45 | $35.86 | $33.52 |
| Selling, general & administrative | $59.84 | $46.55 | $46.99 | $44.17 |
| Total operating expenses | $103.49 | $84 | $82.85 | $77.7 |
| Operating income | -$98.46 | -$84 | -$82.85 | -$77.7 |
| Income from continuing operations | ||||
| EBIT | -$94.32 | -$79.44 | -$77.92 | -$73.42 |
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | -$94.32 | -$79.44 | -$77.92 | -$73.42 |
| Income (for common shares) | -$94.32 | -$79.44 | -$77.92 | -$73.42 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $5.45 | $35 | ||
| Cost of revenue | $0.42 | |||
| Gross Profit | $5.03 | $35 | ||
| Operating activities | ||||
| Research & development | $150.49 | $146.12 | $101.68 | $51.86 |
| Selling, general & administrative | $197.55 | $134.55 | $71.79 | $29.46 |
| Total operating expenses | $348.04 | $280.67 | $173.47 | $81.32 |
| Operating income | -$343.01 | -$280.67 | -$173.47 | -$46.32 |
| Income from continuing operations | ||||
| EBIT | -$325.1 | -$277.42 | -$173.91 | -$45.57 |
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | -$325.1 | -$277.42 | -$173.91 | -$45.57 |
| Income (for common shares) | -$325.1 | -$277.42 | -$173.91 | -$45.57 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$94.32 | -$79.44 | -$77.92 | -$73.42 |
| Operating activities | ||||
| Depreciation | $1.01 | $0.93 | $0.83 | $0.54 |
| Business acquisitions & disposals | -$2.8 | |||
| Stock-based compensation | $25.07 | $23.1 | $22.97 | $23.39 |
| Total cash flows from operations | -$62.7 | -$50.46 | -$47.81 | -$61.82 |
| Investing activities | ||||
| Capital expenditures | $2.3 | -$3.62 | -$3.09 | -$2.98 |
| Investments | -$161.51 | $38.22 | $66.64 | $101.58 |
| Total cash flows from investing | -$159.21 | $34.6 | $60.76 | $98.6 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $299.07 | -$0.24 | -$0.34 | -$1.85 |
| Net borrowings | ||||
| Total cash flows from financing | $299.07 | -$0.24 | -$0.34 | -$1.85 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $77.16 | -$16.1 | $12.6 | $34.94 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$325.1 | -$277.42 | -$173.91 | -$45.57 |
| Operating activities | ||||
| Depreciation | $3.32 | $1.9 | $1.48 | $1.4 |
| Business acquisitions & disposals | -$2.8 | -$4.2 | -$3.5 | |
| Stock-based compensation | $94.53 | $72.97 | $38.44 | $10.03 |
| Total cash flows from operations | -$222.79 | -$161.56 | -$127.88 | -$32.19 |
| Investing activities | ||||
| Capital expenditures | -$7.38 | -$10.2 | -$2.02 | -$0.64 |
| Investments | $44.94 | -$201.2 | $85.61 | -$414.69 |
| Total cash flows from investing | $34.75 | -$215.6 | $83.59 | -$418.83 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $296.64 | $340.7 | $1.16 | $270.49 |
| Net borrowings | ||||
| Total cash flows from financing | $296.64 | $340.7 | $1.16 | $270.49 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $108.6 | -$36.46 | -$43.13 | -$180.54 |
News
Fundamentals
| Market cap | $2.95B |
|---|---|
| Enterprise value | $2.78B |
| Shares outstanding | 73.49M |
| Revenue | $5.45M |
|---|---|
| EBITDA | -$321.78M |
| EBIT | -$325.10M |
| Net Income | -$325.10M |
| Revenue Q/Q | InfinityT% |
| Revenue Y/Y | N/A |
| P/E ratio | -9.06 |
|---|---|
| EV/Sales | 509.86 |
| EV/EBITDA | -8.63 |
| EV/EBIT | -8.54 |
| P/S ratio | 541.00 |
| P/B ratio | 4.71 |
| Book/Share | 8.51 |
| Cash/Share | 2.40 |
| EPS | -$4.42 |
|---|---|
| ROA | -57.04% |
| ROE | -65.69% |
| Debt/Equity | 0.16 |
|---|---|
| Net debt/EBITDA | 0.24 |
| Current ratio | 6.41 |
| Quick ratio | 6.37 |